dr. ryan on bone-targeting agents for patients with prostate cancer
Published 6 years ago • 119 plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
1:26
charles ryan, md: bone-targeted therapy
-
1:12
dr. charles ryan discusses imaagen trial update for prostate cancer
-
1:49
dr. den discusses bone-targeting agents in prostate cancer
-
0:58
dr. araujo on importance of bone-targeting agents in mcrpc
-
3:56
bone-targeted therapy for prostate cancer: radium-223
-
6:11
crpc: preventing complications with bone-targeted agents
-
13:09
radium-223 alone and with other agents for prostate cancer
-
14:14
bone targeted agents in metastatic prostate cancer: denosumab, bisphosphonates and radium-223
-
1:15
dr. ryan on prescribing preferences in prostate cancer and rcc
-
4:55
bone targeted therapy for metastatic prostate cancer
-
4:10
optimal time for prostate cancer bone-targeted therapy
-
5:57
managing bone metastasis in patients with mcrpc
-
1:10
dr. dreicer on challenges of radium-223 in prostate cancer
-
22:16
bone-targeted therapy for prostate cancer
-
17:32
how does #prostatecancer spread to the bones? | spot & injectable radiation | #markscholzmd
-
1:45
targeting plasticity pathways for novel therapy in prostate cancer
-
0:58
dr. den discusses bone metastases in prostate cancer
-
2:37
dr. daniel petrylak discusses novel bone targeted therapies in prostate cancer
-
5:46
treating symptomatic bone metastatic castration-resistant prostate cancer